These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 476698)

  • 1. Quantitation of intracellular metabolites of [35S]-6-mercaptopurine in L5178Y cells grown in time-course incubates.
    Breter HJ; Zahn RK
    Cancer Res; 1979 Sep; 39(9):3744-8. PubMed ID: 476698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cells.
    Liliemark J; Pettersson B; Engberg B; Lafolie P; Masquelier M; Peterson C
    Cancer Res; 1990 Jan; 50(1):108-12. PubMed ID: 2293545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quantitative determination of metabolites of 6-mercaptopurine in biological materials. VI. Evidence for posttranscriptional modification of 6-thioguanosine residues in RNA from L5178Y cells treated with 6-mercaptopurine.
    Breter HJ
    Biochim Biophys Acta; 1985 May; 825(1):39-44. PubMed ID: 4039607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantitative determination of metabolites of 6-mercaptopurine in biological materials. III. The determination of 14C-labeled 6-thiopurines in L5178Y cell extracts using high-pressure liquid cation-exchange chromatography.
    Breter HJ; Maidhof A; Zahn RK
    Biochim Biophys Acta; 1978 Apr; 518(2):205-15. PubMed ID: 418811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemia.
    Wojtuszkiewicz A; Barcelos A; Dubbelman B; De Abreu R; Brouwer C; Bökkerink JP; de Haas V; de Groot-Kruseman H; Jansen G; Kaspers GL; Cloos J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):422-33. PubMed ID: 24940700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of allopurinol on the pharmacokinetics of 6-mercaptopurine in rabbits.
    Tterlikkis L; Day JL; Brown DA; Schroeder EC
    Cancer Res; 1983 Apr; 43(4):1675-9. PubMed ID: 6682007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following iv bolus.
    Narang PK; Chatterji DC; O'Neill D; Poplack DG
    Drug Metab Dispos; 1983; 11(1):5-9. PubMed ID: 6132796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines.
    Zimm S; Johnson GE; Chabner BA; Poplack DG
    Cancer Res; 1985 Sep; 45(9):4156-61. PubMed ID: 2411397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of 6-mercaptopurine by human liver cytosol.
    Rowland K; Lennard L; Lilleyman JS
    Xenobiotica; 1999 Jun; 29(6):615-28. PubMed ID: 10426560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts.
    Bökkerink JP; Stet EH; De Abreu RA; Damen FJ; Hulscher TW; Bakker MA; van Baal JA
    Biochem Pharmacol; 1993 Apr; 45(7):1455-63. PubMed ID: 7682415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gross and cellular analysis of 6-mercaptopurine-induced cleft palate in hamster.
    Burdett DN; Shah RM
    Am J Anat; 1988 Feb; 181(2):179-94. PubMed ID: 3369359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodents.
    Kung MP; Ho YK; Lalka D; Bardos TJ
    Cancer Res; 1984 Oct; 44(10):4602-6. PubMed ID: 6467215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells.
    Wielinga PR; Reid G; Challa EE; van der Heijden I; van Deemter L; de Haas M; Mol C; Kuil AJ; Groeneveld E; Schuetz JD; Brouwer C; De Abreu RA; Wijnholds J; Beijnen JH; Borst P
    Mol Pharmacol; 2002 Dec; 62(6):1321-31. PubMed ID: 12435799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of HPLC to study the kinetics of a branched bi-enzyme system consisting of hypoxanthine-guanine phosphoribosyltransferase and xanthine oxidase--an important biochemical system to evaluate the efficiency of the anticancer drug 6-mercaptopurine in ALL cell line.
    Kalra S; Paul MK; Balaram H; Mukhopadhyay AK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):7-14. PubMed ID: 17081813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured?
    Vikingsson S; Carlsson B; Almer SH; Peterson C
    Ther Drug Monit; 2009 Jun; 31(3):345-50. PubMed ID: 19363461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of intravenously administered high-dose 6-mercaptopurine with and without allopurinol treatment in patients with non-Hodgkin lymphoma.
    Keuzenkamp-Jansen CW; DeAbreu RA; Bökkerink JP; Lambooy MA; Trijbels JM
    J Pediatr Hematol Oncol; 1996 May; 18(2):145-50. PubMed ID: 8846126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia.
    Bostrom B; Erdmann G
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):80-6. PubMed ID: 8447563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 6-mercaptopurine and its metabolites in plasma or serum by high performance liquid chromatography.
    Sahnoun Z; Serre-Debeauvais F; Lang J; Faucon G; Gavend M
    Biomed Chromatogr; 1990 Jul; 4(4):144-7. PubMed ID: 2207374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
    Korelitz BI; Mirsky FJ; Fleisher MR; Warman JI; Wisch N; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed cytotoxicity of 6-mercaptopurine is compatible with mitotic death caused by DNA damage due to incorporation of 6-thioguanine into DNA as 6-thioguanine nucleotide.
    Inamochi H; Higashigawa M; Shimono Y; Nagata T; Cao DC; Mao XY; M'soka T; Hori H; Kawasaki H; Sakurai M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):417-24. PubMed ID: 10606189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.